Cardiovascular disease December 2019 Digest

This site is intended for healthcare professionals only

Filter:

Early blood pressure control reduces atherosclerotic event risk

Early intensive multifactorial therapy reduces stroke risk

Canagliflozin effective in primary and secondary prevention of CV outcomes

GLP-1 receptor agonists significantly improve CV outcomes

GLP-1 receptor agonists have a wide range of benefits

Resources

For the latest news and articles

Resources

Journals

Useful information

;